BUSINESS: Aesthetic Medicine Market Report Up To 2031 Visiongain Research Inc
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Aesthetic Medicine Market Report Up To 2031 Visiongain Research Inc

Visiongain has published a new report on Aesthetic Medicine Market Report to 2031: Forecasts By Product (Invasive Procedures (Breast augmentation, Liposuction, Nose reshaping, Eyelid Surgery, Tummy tuck, and others) Non-invasive Procedures (Botox injections, Soft tissue fillers, Chemical peel, Laser hair removal, Microdermabrasion, and Others) PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/aesthetic-medicine-market/#download_sampe_div COVID-19…

FRONT PAGES: A Potential New Treatment For Inflammatory Arthritis
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

FRONT PAGES: A Potential New Treatment For Inflammatory Arthritis

Newswise — TORONTO – In a paper published today in the journal Science Translational Medicine, researchers at the Schroeder Arthritis Institute, part of University Health Network (UHN) in Toronto, have made a discovery that could lead to new treatments for axial spondyloarthritis (SpA), a painful and debilitating form of arthritis which affects 1-2% of Canadians…

BUSINESS: Global Protein Therapeutics Market (21-2026) – Industry Trends And Size, Growth, Opportunity, And Forecasts
| | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Global Protein Therapeutics Market (21-2026) – Industry Trends And Size, Growth, Opportunity, And Forecasts

DUBLIN, Oct. 18, 2021 /PRNewswire/ — The “Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering. The global protein therapeutics market exhibited moderate growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of around 6% during 2021-2026. Keeping in…

BUSINESS: Global Enzyme Replacement Therapy Market To Reach $15.16 Billion By 2030: Allied Market Research
| | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Global Enzyme Replacement Therapy Market To Reach $15.16 Billion By 2030: Allied Market Research

Increase in the prevalence of rare diseases, availability of wide range of products, and supportive government initiatives for rare diseases drive the growth of the global enzyme replacement therapy market. The Covid-19 pandemic led to decreased public mobility and affected the diagnostic industries. Non-urgent diagnostic procedures and scheduled enzyme replacement therapies were postponed with increase…

BUSINESS: Neurocrine Bisciences To Present ONGENTYS (R) (Opicapone), And INGREZZA (R) (Valbenazine). Data From The American Neurological Association Virtual Annual Meeting
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Neurocrine Bisciences To Present ONGENTYS (R) (Opicapone), And INGREZZA (R) (Valbenazine). Data From The American Neurological Association Virtual Annual Meeting

SAN DIEGO, Oct. 16, 2021 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present key information from its movement disorder treatments for Parkinson’s disease and tardive dyskinesia (TD) at the American Neurological Association (ANA) 2021 Virtual Annual Meeting being held October 17–19, 2021. Neurocrine Biosciences will present new post-hoc analysis of pooled…

BUSINESS: The Global Market For Pharmaceutical Contract Development And Manufacture Is Expected To Grow At 7.3% CAGR
| | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: The Global Market For Pharmaceutical Contract Development And Manufacture Is Expected To Grow At 7.3% CAGR

New York, Oct. 13, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Pharmaceutical Contract Development and Manufacturing Market, End User -Global Forecast to 2026” – https://www.reportlinker.com/p05803740/?utm_source=GNW The increasing demand for biological therapies, growing focus on specialty medicines, growth in the nuclear medicines sector, and advancements in cell and gene therapies are also…

BUSINESS: Injectable Drug Delivery Devices Market Is Anticipated To Increase At A CAGR Of 11.25% And Will Touch USD 33.37 Billion By 2026, States DelveInsight
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Injectable Drug Delivery Devices Market Is Anticipated To Increase At A CAGR Of 11.25% And Will Touch USD 33.37 Billion By 2026, States DelveInsight

The Injectable Drug Delivery Devices market will observe a significant growth owing to the technological advancements in the Injectable Drug Delivery systems such as auto-injectors and needle-free injectors that allow patients to administer drugs in their homes and the effect of Covid-19 pandemic. LAS VEGAS, Oct. 5, 2021 /PRNewswire/ — According to the latest report…

BUSINESS: AbbVie To Showcase New Data At The United European Gastroenterology (UEG) Week Virtual 2021
| | | | | | | | | | | | | | |

BUSINESS: AbbVie To Showcase New Data At The United European Gastroenterology (UEG) Week Virtual 2021

NORTH CHICAGO, Ill., Oct. 2, 2021 /PRNewswire/ — AbbVie today announced new data on the investigational use of risankizumab (SKYRIZI®) in Crohn’s disease, upadacitinib (RINVOQ®) in ulcerative colitis and HUMIRA® (adalimumab) in inflammatory bowel disease (IBD) will be presented as live presentations and e-Posters at the United European Gastroenterology (UEG) Week Virtual 2021, to be held October…

BUSINESS: Inflammatory Bowel Disease Market To Surpass US$ 2,550.3 Million By 2028, Says Coherent Market Insights (CMI)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Inflammatory Bowel Disease Market To Surpass US$ 2,550.3 Million By 2028, Says Coherent Market Insights (CMI)

SEATTLE, Sept. 21, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global inflammatory bowel disease market is estimated to be valued at US$ 1,821.8 million in 2021 and is expected to exhibit a CAGR of 4.9 % during the forecast period (2021-2028). Key Trends and Analysis of the Global Inflammatory Bowel Disease Market:…

BUSINESS: WiCON Publishes The China Pharmaceutical Guide 2021 (16th Edition)
| | | | | | | | | | | |

BUSINESS: WiCON Publishes The China Pharmaceutical Guide 2021 (16th Edition)

Metuchen, NJ, September 21, 2021 –(PR.com)– Chinese Pharma Growth Rebounds from the Pandemic amid Deepening Healthcare and Drug Regulatory ReformWiCON International Group LLC, the publisher of well-known WiCON | Pharma China (www.pharmachinaonline.com), announced that its China Pharmaceutical Guide 2021 (16th Edition) is now officially published.According to the publication, the pandemic also took its tolls on Chinese…

BUSINESS: Junshi Biosciences And Coherus To Present Positive Progression Free Survival And Overall Survival Results From JUPITER-06, A Phase 3 Clinical Trial Evaluating Toripalimab In Combination With Chemotherapy As First-Line Treatment For Advanced Esophageal Squamous Cell Carcinoma
| | | | | | | | | | | | | | |

BUSINESS: Junshi Biosciences And Coherus To Present Positive Progression Free Survival And Overall Survival Results From JUPITER-06, A Phase 3 Clinical Trial Evaluating Toripalimab In Combination With Chemotherapy As First-Line Treatment For Advanced Esophageal Squamous Cell Carcinoma

September 16, 2021 20:19 ET | Source: Junshi Biosciences – Interim results to be presented September 17 at the European Society for Medical Oncology (ESMO) Congress 2021 – – Data support the use of toripalimab with chemotherapy as first-line therapy for patients with ESCC – – Coherus and Junshi Biosciences plan to submit a BLA supplement for 1L ESCC…

BUSINESS: Migraine Pipeline Space Brims With Novel Emerging Therapies With Over 30 Pharma Players Working In The Domain |DelveInsight
| | | | | | | |

BUSINESS: Migraine Pipeline Space Brims With Novel Emerging Therapies With Over 30 Pharma Players Working In The Domain |DelveInsight

The Migraine Pipeline landscape is robust and fueled with new therapies which hold the promise to change the migraine treatment regimen in coming years. September 16, 2021 20:00 ET | Source: DelveInsight Business Research LLP Los Angeles, USA, Sept. 16, 2021 (GLOBE NEWSWIRE) — Migraine Pipeline Space Brims with Novel Emerging Therapies with Over 30…

BUSINESS: Psoriatic Arthritis Treatment Market To Surpass US$ 17,765.0 Million By 2028, Says Coherent Market Insights (CMI)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Psoriatic Arthritis Treatment Market To Surpass US$ 17,765.0 Million By 2028, Says Coherent Market Insights (CMI)

SEATTLE, Sept. 14, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global psoriatic arthritis treatment market is estimated to be valued at US$ 10,100.9 million in 2021 and is expected to exhibit a CAGR of 8.4% over the forecast period (2021-2028). Key Trends and Analysis of the Global Psoriatic Arthritis Treatment Market: Key…

| | | | |

BUSINESS: AbbVie & REGENXBIO Announce Eyecare Collaboration

NORTH CHICAGO, Ill. and ROCKVILLE, Md., Sept. 13, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced a partnership to develop and commercialize RGX-314, a potential one-time gene therapy for the treatment of wet age-related macular degeneration (wet…

End of content

End of content